Copyright
©The Author(s) 2015.
World J Gastroenterol. Oct 14, 2015; 21(38): 10760-10775
Published online Oct 14, 2015. doi: 10.3748/wjg.v21.i38.10760
Published online Oct 14, 2015. doi: 10.3748/wjg.v21.i38.10760
Before LT | After LT | |
Aim | Prevention of HCV recurrence | Treatment of HCV recurrence |
Advantages | Undetectable HCV-RNA at transplantation correlates with low rates of post-LT HCV recurrence | Increased tolerance to treatment |
Disadvantages | Low eligibility due to compromised baseline conditions | High rates of adverse effects |
High rates of serious side effects and discontinuation rates | Moderate SVR rates | |
Low SVR rates | Drug-drug interactions |
- Citation: Righi E, Londero A, Carnelutti A, Baccarani U, Bassetti M. Impact of new treatment options for hepatitis C virus infection in liver transplantation. World J Gastroenterol 2015; 21(38): 10760-10775
- URL: https://www.wjgnet.com/1007-9327/full/v21/i38/10760.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i38.10760